Line Schmidt Tarpgaard

2.2k total citations
27 papers, 471 citations indexed

About

Line Schmidt Tarpgaard is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Line Schmidt Tarpgaard has authored 27 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Line Schmidt Tarpgaard's work include Colorectal Cancer Treatments and Studies (11 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Line Schmidt Tarpgaard is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Line Schmidt Tarpgaard collaborates with scholars based in Denmark, Sweden and Norway. Line Schmidt Tarpgaard's co-authors include Per Pfeiffer, Benny Vittrup Jensen, Torben Frøstrup Hansen, Claus L. Andersen, Mads H. Rasmussen, Camilla Qvortrup, Jan Stenvang, Torben F. Ørntoft, Flemming Hansen and Tine Plato Hansen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Line Schmidt Tarpgaard

24 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Line Schmidt Tarpgaard Denmark 10 213 197 179 95 85 27 471
Haiqing Ma China 12 145 0.7× 188 1.0× 150 0.8× 57 0.6× 90 1.1× 13 518
Sumitra Ananda Australia 12 224 1.1× 133 0.7× 89 0.5× 46 0.5× 85 1.0× 54 468
Tiago Biachi De Castria Brazil 14 261 1.2× 96 0.5× 135 0.8× 188 2.0× 337 4.0× 53 626
Yingjie Shao China 9 200 0.9× 202 1.0× 151 0.8× 105 1.1× 104 1.2× 12 492
Emanuela Dell’Aquila Italy 12 362 1.7× 171 0.9× 242 1.4× 56 0.6× 189 2.2× 41 593
Suebpong Tanasanvimon Thailand 10 285 1.3× 160 0.8× 67 0.4× 257 2.7× 128 1.5× 34 536
Sugganth Daniel United States 7 196 0.9× 62 0.3× 70 0.4× 46 0.5× 96 1.1× 26 313
Bingjie Leng China 5 233 1.1× 171 0.9× 185 1.0× 42 0.4× 100 1.2× 8 441
K.M. Tveit Norway 8 351 1.6× 191 1.0× 175 1.0× 186 2.0× 85 1.0× 16 580
Isabelle Baumgaertner France 11 442 2.1× 185 0.9× 167 0.9× 263 2.8× 222 2.6× 21 725

Countries citing papers authored by Line Schmidt Tarpgaard

Since Specialization
Citations

This map shows the geographic impact of Line Schmidt Tarpgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Schmidt Tarpgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Schmidt Tarpgaard more than expected).

Fields of papers citing papers by Line Schmidt Tarpgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Schmidt Tarpgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Schmidt Tarpgaard. The network helps show where Line Schmidt Tarpgaard may publish in the future.

Co-authorship network of co-authors of Line Schmidt Tarpgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Line Schmidt Tarpgaard. A scholar is included among the top collaborators of Line Schmidt Tarpgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Schmidt Tarpgaard. Line Schmidt Tarpgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burton, Mark, Alan Patrick Ainsworth, Claus Wilki Fristrup, et al.. (2025). Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. Pathology - Research and Practice. 275. 156250–156250.
2.
Ainsworth, Alan Patrick, Sönke Detlefsen, Claus Wilki Fristrup, et al.. (2024). Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). SHILAP Revista de lepidopterología. 9(2). 69–77. 1 indexed citations
3.
Detlefsen, Sönke, Mark Burton, Alan Patrick Ainsworth, et al.. (2024). RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). SHILAP Revista de lepidopterología. 9(2). 79–91. 2 indexed citations
4.
Tarpgaard, Line Schmidt, Stine Brændegaard Winther, & Per Pfeiffer. (2023). Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies. Cancers. 16(1). 126–126. 3 indexed citations
5.
6.
Fristrup, Claus Wilki, Alan Patrick Ainsworth, Sönke Detlefsen, et al.. (2023). What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC). SHILAP Revista de lepidopterología. 8(4). 147–155. 8 indexed citations
7.
8.
9.
Graversen, Martin, Ioannis Rouvelas, Alan Patrick Ainsworth, et al.. (2023). Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence—The PIPAC-OPC4 Study. Annals of Surgical Oncology. 30(7). 4433–4441. 9 indexed citations
10.
Graversen, Martin, Sönke Detlefsen, Alan Patrick Ainsworth, et al.. (2023). Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study. Annals of Surgical Oncology. 30(5). 2634–2644. 26 indexed citations
11.
Detlefsen, Sönke, Alan Patrick Ainsworth, Claus Wilki Fristrup, et al.. (2022). Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC). SHILAP Revista de lepidopterología. 7(3). 143–148. 6 indexed citations
12.
Tarpgaard, Line Schmidt, Jiří Bártek, & Per Pfeiffer. (2021). P-221 Repurposing disulfiram as treatment for metastatic colorectal cancer: An investigator-initiated clinical phase II trial. Annals of Oncology. 32. S174–S175. 3 indexed citations
13.
Jeppesen, Stefan Starup, et al.. (2020). Quality of life in patients with cancer during the COVID-19 pandemic – a Danish cross-sectional study (COPICADS). Acta Oncologica. 60(1). 4–12. 43 indexed citations
14.
Palshof, Jesper Andreas, Estrid Høgdall, Tim Svenstrup Poulsen, et al.. (2017). Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer. BMC Cancer. 17(1). 48–48. 17 indexed citations
15.
Tarpgaard, Line Schmidt, Camilla Qvortrup, Sune Boris Nygård, et al.. (2016). A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. BMC Cancer. 16(1). 91–91. 27 indexed citations
16.
Rasmussen, Mads H., Iben Lyskjær, Rosa Jersie-Christensen, et al.. (2016). miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells. Nature Communications. 7(1). 12436–12436. 70 indexed citations
17.
Lin, Xue, Jan Stenvang, Mads H. Rasmussen, et al.. (2015). The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer. BMC Genomics. 16(1). 404–404. 12 indexed citations
18.
Tarpgaard, Line Schmidt, Tormod Kyrre Guren, Bengt Glimelius, et al.. (2014). Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study. PLoS ONE. 9(2). e87746–e87746. 17 indexed citations
19.
Boisen, Mogens K., Julia S. Johansen, Christian Dehlendorff, et al.. (2013). Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer. Annals of Oncology. 24(10). 2554–2559. 76 indexed citations
20.
Rasmussen, Mads H., Niels F. Jensen, Line Schmidt Tarpgaard, et al.. (2013). High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer. Molecular Oncology. 7(3). 637–646. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiqing Ma Breakdown of academic impact, for papers by Sumitra Ananda Breakdown of academic impact, for papers by Tiago Biachi De Castria Breakdown of academic impact, for papers by Yingjie Shao Breakdown of academic impact, for papers by Emanuela Dell’Aquila Breakdown of academic impact, for papers by Suebpong Tanasanvimon Breakdown of academic impact, for papers by Sugganth Daniel Breakdown of academic impact, for papers by Bingjie Leng Breakdown of academic impact, for papers by K.M. Tveit Breakdown of academic impact, for papers by Isabelle Baumgaertner
Rankless by CCL
2026